News

Senior engineering students adapted interactive toys and bouncers for 12-year-old boy born with Peroxisomal Biogenesis ...
New research identifies the liver protein PTPRD as a key regulator of metabolic liver disease. Reduced levels of PTPRD disrupt glucose and lipid metabolism, promote liver fat accumulation, and impair ...
- LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and Progressive Familial Intrahepatic Cholestasis in Japan “We are thrilled to ...